-
DailyClout Makes Legislation Easy to Understand, Share and Act Upon
Join the Community
Search BillCam
-
LET'S SAVEDEMOCRACYTOGETHER
May 13, 2022
Daniel B. Demers, PhD
Report 05: Pfizer mRNA Construct – Why Spike Protein Causes Disease
Introduction In the first paragraph of Pfizer document 2.4 NONCLINICAL OVERVIEW, Pfizer states that “BNT162b2 is a nucleoside modified mRNA (modRNA) expressing full-length S [spike] with two proline mutations (P2) to lock the transmembrane protein in an antigenically optimal prefusion conformation” (p. 6, https://www.phmpt.org/wp-content/uploads2022/03/125742_S1_M2_24_nonclinical-overview.pdf). They list two references (Pallesen …
May 13, 2022
Cindy Weis
Report 18: Vaccine ‘Shedding’: Can This Be Real After All?
Vaccine ‘Shedding’: Can This Be Real After All? That question, as we have been told, was put to rest over a year ago by the experts who follow the science. But recently, I have been reading with alarm the reports of hepatitis in young children. Currently, the suspected …
May 12, 2022
DailyClout
‘Ultra-Maga’ OK..!
Rob Carson Show Newsmax ‘Ultra-Maga OK..! The Newsmax Daily Rob Carson Show. Roe v Wade is now assuredly set to be overturned, as Karens who don’t represent the people affected by it (as usual) still protest in oblivion. Gas prices continue to rise as we lose our oil reserves thanks …
May 12, 2022
War Room/DailyClout Pfizer Documents Analysis Project Team 5
Report 19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Team Five: Review of Polack with comments and questions. “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” Fernando P. Polack, M.D., Stephen J. Thomas, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Gonzalo Perez Marc, M.D., Edson D. Moreira, …
May 11, 2022
Daniel B. Demers, PhD
Report 22: Effects of N1-Methyl-Pseudouridine in the Pfizer mRNA Vaccine
Daily Clout 5/9/22 Report: Effects of N1-methyl-pseudouridine in the Pfizer mRNA Vaccine Researcher/Author: Daniel B. Demers, PhD Reviewed by: Team 5 Introduction The use of messenger RNA (mRNA) vaccines has been developing since 1990. Historically, there have been three significant problems associated with mRNA vaccines. First, it has always been …

Search BillCam





